Skip to main content

Advertisement

ADVERTISEMENT

Volume 18 - Issue 10 - October, 2006

Feature

Original Contribution
08/01/2008
*Jason Call, MD, Matthew Sacrinty, MPH, Robert Applegate, MD, William Little, MD, Renato Santos, MD, Talal Baki, MD, Sanjay Gandhi, MD, Frederic Kahl, MD, Michael Kutcher, MD
*Jason Call, MD, Matthew Sacrinty, M...
Contrast-induced nephropathy (CIN) is a common problem after cardiac catheterization and percutaneous coronary intervention (PCI), and is associated with substantial morbidity and mortality.1–3 The etiology of CIN has not been clearly...
Contrast-induced nephropathy (CIN) is a common problem after cardiac catheterization and percutaneous coronary intervention (PCI), and is associated with substantial morbidity and mortality.1–3 The etiology of CIN has not been clearly...
Contrast-induced nephropathy...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Demosthenes G. Katritsis, MD, PhD, FRCP, Socrates Korovesis, MD, Evangelia Karvouni, MD, Eleftherios Giazitzoglou, MD, Spyridoula Theodorou, MD, Georgia Kourlaba, MD, Demosthenes Panagiotakos, MD, Eutychios Voridis, MD
Demosthenes G. Katritsis, MD, PhD, FR...
Several randomized studies with bare-metal stents (BMS) have demonstrated the feasibility of direct stenting in a high percentage of coronary lesions, with low crossover rates of approximately 6%.1–13 Most studies have failed to detect...
Several randomized studies with bare-metal stents (BMS) have demonstrated the feasibility of direct stenting in a high percentage of coronary lesions, with low crossover rates of approximately 6%.1–13 Most studies have failed to detect...
Several randomized studies with...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Massimo Margheri, MD, Massimiliano Falai, MD, Guido Vittori, MD, *Giuseppe G.L. Biondi Zoccai, MD, Tania Chechi, MD, Ilaria Ricceri, MD, Elena Falchetti, MD, Marco Comeglio, MD, Cristina Giglioli, MD, Serafina Valente, MD, Gian Franco Gensini, MD
Massimo Margheri, MD, Massimiliano F...
Percutaneous coronary intervention (PCI) is a mainstay in the management of acute myocardial infarction (AMI).1 However, despite major improvements in technical and pharmacologic means, including stent implantation and the use of potent...
Percutaneous coronary intervention (PCI) is a mainstay in the management of acute myocardial infarction (AMI).1 However, despite major improvements in technical and pharmacologic means, including stent implantation and the use of potent...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Tim A. Fischell, MD, Tamer Attia, MD, Santosh Rane, MD, Waddah Salman, MD
Tim A. Fischell, MD, Tamer Attia, MD...
Rupture of an atherosclerotic coronary arterial plaque, as occurs spontaneously in patients with acute coronary syndromes, or as the result of a percutaneous coronary intervention (PCI), may serve as a stimulus for platelet adhesion,...
Rupture of an atherosclerotic coronary arterial plaque, as occurs spontaneously in patients with acute coronary syndromes, or as the result of a percutaneous coronary intervention (PCI), may serve as a stimulus for platelet adhesion,...
Rupture of an atherosclerotic...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
aFernando Cura, MD, aMariano Albertal, MD, PhD, bWilliam O’Neill, MD, cJose Milei, MD, aLucio Padilla, MD, aPablo Perez Baliño, MD, aMarcelo Trivi, MD, aJorge Belardi, MD
aFernando Cura, MD, aMariano Alberta...
Signs of suboptimal myocardial reperfusion are frequently encountered following primary angioplasty and this phenomenon is associated with poor left ventricular wall motion recovery and unfavorable clinical outcomes.1–4 Patients with acute...
Signs of suboptimal myocardial reperfusion are frequently encountered following primary angioplasty and this phenomenon is associated with poor left ventricular wall motion recovery and unfavorable clinical outcomes.1–4 Patients with acute...
Signs of suboptimal myocardial...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Jason H. Rogers, MD, Jacob Wegelin, PhD, Kori Harder, RN, Richard Valente, MD, Reginald Low, MD
Jason H. Rogers, MD, Jacob Wegelin, ...
Assessing the clinical importance of angiographically intermediate coronary artery stenoses (> 40% and
Assessing the clinical importance of angiographically intermediate coronary artery stenoses (> 40% and
Assessing the clinical...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
David G. Rizik, MD, Kevin J. Klassen, MD, Denise A. Dowler, MSNP, Bernard J. Villegas, MD
David G. Rizik, MD, Kevin J. Klassen...
Compared to the use of bare-metal stents (BMS), drug-eluting stents (DES) have been shown to reduce the rate of restenosis in bifurcation coronary artery disease.1 Specifically, the segment demonstrating the greatest susceptibility to...
Compared to the use of bare-metal stents (BMS), drug-eluting stents (DES) have been shown to reduce the rate of restenosis in bifurcation coronary artery disease.1 Specifically, the segment demonstrating the greatest susceptibility to...
Compared to the use of...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Pasi P. Karjalainen, MD, Antti Ylitalo, MD, PhD, Juhani K.E. Airaksinen, MD, FESC
Pasi P. Karjalainen, MD, Antti Ylital...
Coronary stents have reduced the risk of periprocedural complications and restenosis compared to balloon angioplasty alone.1,2 In spite of this progress, restenosis is still a clinical problem of bare metal stents, particularly in certain...
Coronary stents have reduced the risk of periprocedural complications and restenosis compared to balloon angioplasty alone.1,2 In spite of this progress, restenosis is still a clinical problem of bare metal stents, particularly in certain...
Coronary stents have reduced the...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
08/01/2008
Proddutur Raghuveer Reddy, MD, *Aravinda Nanjundappa, MD, RVT, Robert S. Dieter, MD, RVT
Proddutur Raghuveer Reddy, MD, *Arav...
Distal embolic protection devices (DEPD) were developed from the necessity of protecting against macroparticle embolization. These devices are routinely used in saphenous vein graft (SVG) interventions and carotid artery stenting, and have...
Distal embolic protection devices (DEPD) were developed from the necessity of protecting against macroparticle embolization. These devices are routinely used in saphenous vein graft (SVG) interventions and carotid artery stenting, and have...
Distal embolic protection...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
James Hermiller, MD and Ali Rizvi, MD
James Hermiller, MD and Ali Rizvi, MD...
Bifurcation disease continues to be one of the complex coronary lesion subsets that remains a challenge. The percutaneous treatment of bifurcations is common, accounting for up to 20% of interventions, and the frequency has increased in the...
Bifurcation disease continues to be one of the complex coronary lesion subsets that remains a challenge. The percutaneous treatment of bifurcations is common, accounting for up to 20% of interventions, and the frequency has increased in the...
Bifurcation disease continues to...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement